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Abstract
The study of the SUP45 and SUP35 genes of yeast Saccharomyces cerevisiae in 
the laboratory of Physiological Genetics of St. Petersburg State University be-
gan in 1964 when the first omnipotent nonsense suppressor mutations were 
obtained. During the following 55 years, a lot of information about these genes 
has been gained through the research efforts of various laboratories. Now we 
know that SUP45 and SUP35 encode translation termination factors eRF1 and 
eRF3, respectively. Both genes are essential, and sup45 and sup35 mutations 
lead not only to impaired translation but also to multiple pleiotropic effects. 
The aim of this review is to summarize known data about suppressor mutations 
in SUP45 or SUP35 genes.
Keywords: translation termination, suppression, SUP45, SUP35, eRF1, eRF3, 
nonsense mutations, missense mutations, [PSI+] prion, S. cerevisiae.
Introduction
In eukaryotes, translation termination requires two eukaryotic release factors: 
eRF1 and eRF3. The eRF1 protein belongs to class 1 translation termination fac-
tors, responsible for the recognition of the stop codon and peptidyl-tRNA hydro-
lysis, and eRF3 — to class 2 termination factors, functioning to stimulate the work 
of class 1  factors due to its GTPase activity. Most eukaryotic organisms have a 
single class 1 translation termination factor called eRF1 (Frolova et al., 1994) that 
recognizes all three stop codons. In eukaryotic cells, class 2 translation termina-
tion factors are represented by eRF3 proteins (Stansfield et al., 1995a; Zhourav-
leva et al., 1995). Although all living organisms have a similar general transla-
tion termination mechanism, there are significant differences primarily between 
prokaryotes and eukaryotes (see review by Kisselev et al., 2003). During the last 
years several additional proteins participating in eukaryotic translation termina-
tion have been identified, including ABCE1 (Rli1 in S. cerevisiae), Dbp5, PABP, 
Hrp1, Pub1 and Upf proteins (see reviews by Tieg and Krebber, 2013; Schuller 
and Green, 2018).
It should be noted that the role of translation termination factors in the cell 
seems not to be limited to participation in translation termination, and these pro-
teins are also likely to be involved in other stages of translation and different cel-
lular processes.
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The main goal of this review is to summarize known 
data about suppressor mutations isolated in SUP35  or 
SUP45 genes with an emphasis on results obtained in the 
Department of Genetics and Biotechnology of St.  Pe-
tersburg State University.
1. The history of the discovery of  
the SUP45 and SUP35 genes
The study of the SUP35  (SUP2)  gene and functionally 
linked SUP45 (SUP1) gene in S. cerevisiae has a history 
of more than fifty years. In 1964, the mutations in these 
genes, named s1 and s2, recessive omnipotent nonsense 
suppressors, were obtained in the laboratory of Physio-
logical Genetics of St. Petersburg State University (Inge-
Vechtomov, 1964). The mutations in these genes caused 
the suppression of nonsense codons of all three types 
(Inge-Vechtomov and Andrianova, 1970), or omnipo-
tent suppression. Developing a specific selection system 
for recessive suppressors promoted their further study. 
Haploid strains carrying the ade1–14 and his7–1 muta-
tions (later identified as nonsense mutations UGA and 
UAA, respectively) were shown to revert to prototrophy 
mostly due to mutations in the genes s1 and s2  (Inge-
Vechtomov and Andrianova, 1972). A similar phenom-
enon was found with simultaneous reversions to proto-
trophy for histidine and lysine in double mutants his7-
1 (UAA) lys2-87 (UGA) (Inge-Vechtomov et al., 1988). 
Later, similar omnipotent suppressor mutations were 
described in other laboratories: sup35  и  sup45  (Haw-
thorne and Leupold, 1974), supP and supQ (Gerlach, 
1975). After that, by using the allelism test, it was shown 
that sup1=sup45=supQ, аnd sup2=sup35=supP (see 
Sherman, 1982). When searching for genes affecting the 
translation fidelity, in the strain [PSI+], the weak om-
nipotent suppressors sup36 and sup47 were isolated, that 
also turned out to be SUP35 и SUP45, alleles, respective-
ly (Ono et al., 1984). Moreover, the GST1 gene (Kikuchi 
et al., 1988), a mutation in which led to the cell cycle 
block at the G1-S phase, also turned out to be identical 
to the SUP35 gene. 
In the search for allosuppressor mutations that could 
increase the suppression efficiency of the weak domi-
nant suppressor SUQ5, the SAL3 and SAL4 genes were 
found, which proved to be identical to the SUP35 and 
SUP45  genes (Crouzet and Tuite, 1987; Crouzet et al., 
1988). Thus, various genetic approaches allowed iden-
tification of the genes, mutations in which led to re-
cessive omnipotent suppression, allosuppression, cell 
cycle disorders, as well as numerous pleiotropic effects. 
These genes were commonly referred to as SUP45 (for 
sup1)  and SUP35  (for sup2), with their identity being 
confirmed by their cloning and sequencing (Surguchev 
et al., 1983; Breining et al., 1984; Himmelfarb et al., 1985; 
Telkov et al., 1986; Breining and Piepersberg, 1986; 
Crouzet and Tuite, 1987; Crouzet et al., 1988; Kushnirov 
et al., 1988; Wilson and Culbertson, 1988). 
Genetic research data collected by the early 1990s 
led to a conclusion that the products of the SUP45 and 
SUP35 genes are involved in the control of translation 
fidelity, with this fact being confirmed by the analysis 
of biochemical data. In vitro ribosomes isolated from 
mutants sup45 and sup35 showed a high level of errors, 
with defective Sup45 and Sup35 proteins being associ-
ated with the 40S subunit of the ribosome (Eustice et 
al., 1986). Later studies confirmed this and showed that 
Sup45 and Sup35 proteins interact with monosomes and 
polysomes, this association being stronger than with the 
40S subunit (Didichenko et al., 1991; Stansfield et al., 
1992). 
The cloning and sequencing of the SUP45  and 
SUP35 genes showed that they encode proteins of 49 and 
77 kDa, respectively (Himmelfarb et al., 1985; Breining 
and Piepersberg, 1986; Kushnirov et al., 1988; Wilson 
and Culbertson, 1988), their size exceeding the size of 
known ribosomal proteins. Moreover, the SUP45  gene 
was expressed at a rather low level, since SUP45 mRNA 
was only 1/10 of the level of mRNA of the L3 ribosomal 
protein (Himmelfarb et al., 1985). While Sup45  pro-
tein did not reveal homology with any of the proteins 
known at that time (Breining and Piepersberg, 1986), 
the C-terminal domain of Sup35 protein was 37 % iden-
tical to the yeast elongation factor eEF1-A (Kushnirov et 
al., 1988; Wilson and Culbertson, 1988). Taken together, 
these data suggest that Sup45 and Sup35 proteins may 
be translational factors closely associated with the small 
40S subunit of the ribosome (Himmelfarb et al., 1985; 
Kushnirov et al., 1988; Wilson and Culbertson, 1988).
The estimation of the relative content of Sup45 and 
Sup35 proteins over the ribosomal fraction showed that 
each of these proteins is present in a cell in a ratio of 1 to 
20 ribosomes (Didichenko et al., 1991; Stansfield et al., 
1992). Consequently, Sup45 and Sup35 were more likely 
to be the factors of initiation or termination, rather than 
translation elongation, since the latter are usually pres-
ent in equal stoichiometric ratios with the ribosomes 
(see review by Stansfield and Tuite, 1994).
The available biochemical data served as evidence 
for Sup45 and Sup35 proteins participating in the termi-
nation process, rather than translation initiation. Thus, 
even earlier studies proved a thermosensitive mutation 
in the SUP35  gene to cause the disruption of protein 
synthesis (Smirnov et al., 1974) and accumulation of 80S 
ribosomes associated with peptidyl-tRNA (Smirnov et 
al., 1976). The identification of various types of tRNA 
complex allowed one to suggest that the defect under 
study was associated with translation termination but 
not translation initiation, as in the latter case, tRNAMet 
would be the main component of the peptidyl-tRNA 
complex (Surguchov et al., 1980). The omnipotent sup-
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pressor phenotype of the sup45 and sup35 mutants also 
suggested defects in the translation termination process. 
The deletion analysis of the corresponding gene 
provided further evidence of Sup35 protein involvement 
in termination. In the Sup35  protein, one can identify 
three domains bounded by methionines at 1, 124, and 
254  amino acid (aa) positions (Figure 1A). These do-
mains differ in a number of properties. The N-terminal 
domain (aa 1-123) is enriched in Q and N residues and 
contains oligopeptide repeats. The M-domain (aa 124-
253) is enriched with charged amino acid residues. The 
C-terminal domain (aa 254-685) reveals homology with 
the elongation factor eEF1-A. The SUP35  gene (simi-
lar to the SUP45 gene) is an essential gene (see below). 
The presence of only the C-terminal domain in the cell 
proved to be sufficient to compensate for the deletion 
of this gene. At the same time, the TEF1 gene, encod-
ing eEF1-A, could not compensate for the deletion of the 
SUP35 gene, indicating the difference in the functions of 
eEF1-A and Sup35 proteins during the translation pro-
cess. An increase in the content of the C-terminal do-
main in the cell led to anti-suppression (Ter-Avanesyan 
et al., 1993), while the over-expression of the full-length 
SUP35 gene (or its N-terminal domain) caused omnipo-
tent suppression (Chernoff et al., 1988; Chernoff et al., 
1993; Ter-Avanesyan et al., 1993; Derkatch et al., 1996). 
Later, the prion hypothesis enabled these results to be 
explained. 
By the beginning of the 1990s, in yeast, two cyto-
plasmic allosuppressors were found, identified as [PSI+] 
(Cox, 1965) and [ETA+] (Liebman and All-Robyn, 
1984). The [PSI+] factor increased the suppression of 
weak tRNA suppressors, such as SUQ5 (Cox, 1965) and 
resulted in lethality in combination with SUP11-o and 
SUP3-o (Cox, 1971). The [ETA+] factor, in turn, resulted 
in lethality in combination with sup35-2  and sup45-
2 mutations but did not affect the viability of the other 
sup35  and sup45  mutants under study (Liebman and 
All-Robyn, 1984; All-Robyn et al., 1990). Later, [PSI+] 
and [ETA+] were shown to be different forms of the same 
factor [PSI+] (Zhou et al., 1999). For a long time, the mo-
lecular nature of this factor remained inexplicable until 
it was shown that the [PSI+] factor is a product of the 
SUP35 gene (Chernoff et al., 1993; Doel et al., 1994; Ter-
Avanesyan et al., 1994). Not long after that, R. Wikner 
suggested that Sup35  protein might be a yeast prion 
(Wickner, 1994).
Thus, by the beginning of the 1990s, the exact role 
of Sup45  and Sup35  proteins in translation remained 
unidentified. Although in early works, Sup45  and 
Sup35 proteins were supposed to be involved in trans-
lation termination (Inge-Vechtomov and Andrianova, 
1970), the lack of homology with prokaryotic release 
factors (RF), as well as the absence of an anti-suppressor 
effect during overexpression did not allow them to be 
considered as translation factors (see Stansfield and Tu-
ite, 1994). It was assumed that these proteins could play a 
supporting role in translation termination by interacting 
with release factors or with ribosomes. While prokary-
otic translation release factors were first characterized a 
long time ago (Craigen et al., 1985; Craigen and Caskey, 
1987), the eukaryotic termination factors remained un-
identified for a long time. The cloning of cDNA encod-
ing the RF of a rabbit was reported in 1990 (Lee et al., 
1990). A surprisingly high degree of similarity between 
the protein and tryptophanyl-tRNA synthetase identi-
fied served as evidence that the identified gene encodes 
the rabbit tryptophanyl synthetase but not the RF factor 
(Frolova et al., 1993). Even in early experiments, transla-
tion termination in mammals was demonstrated to be a 
GTP-dependent process (Beaudet and Caskey, 1971; Ko-
necki et al., 1977), but to isolate a protein with GTPase 
activity was not possible. 
In 1994, the laboratory of L. L. Kiselev in collabora-
tion with some foreign laboratories found Sup45 protein 
to be a termination factor capable of recognizing stop 
codons (Frolova et al., 1994). Due to this property, it was 
named eRF1  and, together with the bacterial proteins 
RF1 and RF2, was assigned to class 1  termination fac-
tors. The following year, data was obtained that was sig-
nificant to establish the role of Sup35 protein as a second 
termination factor; it was named eRF3 because its func-
tions are analogous to the bacterial RF3 (Zhouravleva et 
al., 1995).
2. Molecular mechanism of the translation 
termination process in eukaryotes
In eukaryotes, for efficient translation termination, it is 
necessary that eRF1 should interact directly with eRF3 in 
the presence of GTP (Stansfield et al., 1995a; Zhouravleva 
et al., 1995; Frolova et al., 1996). It was shown that the 
interaction of the yeast eRF1 and eRF3 is possible only if 
eRF3 is associated with GTP (Kobayashi et al., 2004). This 
interaction is supposed to lead to conformational changes 
that allow eRF1 to interact efficiently with the stop codon 
in the A-site of the ribosome. Conformational rearrange-
ments seem to be necessary for the exact correspondence 
of the distance between the GGQ motif and the “protein 
anticodon” in eRF1 (80 Å) and the distance between the 
peptidyl-transferase center of the ribosome and the stop 
codon (75 Å). However, the binding of the termination 
factors to the ribosome is not enough to effectively ter-
minate translation. Additional conformational changes in 
the structure of eRF1 are required to correctly orient the 
GGQ motif in the peptidyl transferase center (Alkalaeva 
et al., 2006). The energy for such a rearrangement is pro-
vided by the hydrolysis of GTP by the eRF3. The eRF3 as-
sociated with GDP dissociates from eRF1 (Kobayashi et 
al., 2004). Given the above, the role of the eRF3 in transla-
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Fig. 1. The mutations obtained in the SUP35 gene. 
A. Sup35p consists of three domains: N, M and C, which were assigned by positions of three ATG codons in the SUP35 sequence (Kush-
nirov et al., 1988). N-domain includes two regions: QN-rich and oligopeptide repeats (OR), which are needed for [PSI+] formation and 
propagation. M-domain is enriched with charged aa and contains the site for Hsp104  chaperon binding (Helsen and Glover, 2012). 
Together N and M domains are involved in prion forming domain of Sup35p (PFD). Essential C-domain containing GTP (Kushnirov et al., 
1987; Hoshino et al., 1998) and eRF1 (Paushkin et al., 1997; Ito et al., 1998; Ebihara and Nakamura, 1999; Merkulova et al., 1999) binding 
sites perform main functional role of Sup35 as translation termination factor eRF3. C-domain shows homology with elongation factor 
eEF-1A and EF-Tu (Kushnirov et al., 1987; Kong et al., 2004). B. Nonsense mutations in SUP35 gene obtained in our laboratory (Chabel-
skaya et al., 2004). Numbers above Sup35 protein scheme correspond to numbers of sup35 mutations. PTC (premature termination 
codon) positions match to the aa length of truncated proteins formed in the case of translation termination on the sup35 mutation. 
C. Missense mutations in SUP35 gene obtained in different laboratories (Volkov et al., 2002; 2007; Bradley et al., 2003; Chabelskaya et 
al., 2004; Kobayashi et al., 2004; Salas-Marco and Bedwell, 2004; Fabret et al., 2008 and our unpublished data). Alignment of S. cerevisiae 
Sup35 and H. sapiens GSPT1 C-domains is shown. The triangle sign — single missense mutations (stacks of them correspond to hotspot 
mutation sites). The star sign shows double mutation G365V/E559K (Chabelskaya et al., 2004). Underlined six aa and the circle sign mean 
six aa duplication (Chabelskaya et al., 2004). GTP and eRF1 binding sites are underlined. 
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tion termination was supposed to be reduced to a change 
in the conformational states of eRF1 (Alkalaeva et al., 
2006; Fan-Minogue et al., 2008). 
A distinctive feature of eRF3 is its ability to form a 
stable complex with eRF1 (Stansfield et al., 1995a; Zho-
uravleva et al., 1995; Frolova et al., 1998) due to the inter-
action between the C-terminal domains of both factors 
(Ito et al., 1998; Ebihara and Nakamura, 1999; Merku-
lova et al., 1999). It was assumed that eRF3 might play 
a role similar to bacterial RF3 by providing “recycling” 
(Zavialov et al., 2001). However, according to genetic 
data, the eRF3 GTPase activity is needed both to ensure 
correct recognition of stop codons by the eRF1 and for 
subsequent release of the newly synthesized peptide (Sa-
las-Marco and Bedwell, 2004). Taken together, the above 
data, as well as the translation termination simulation 
in vitro, made it possible to modify the existing transla-
tion termination model (Alkalaeva et al., 2006). eRF3 is 
believed to bind to the ribosome in the presence of GTP, 
and the subsequent hydrolysis of GTP is necessary for 
eRF1 to be able to induce the release of the newly syn-
thesized polypeptide. The model given is consistent with 
the results of the crystal structure characteristics of the 
eRF3 (aa 196-662) C-terminal domain of Schizosaccha-
romyces pombe (Kong et al., 2004). Functional differ-
ences between eRF3  and RF3  may be due not only to 
their different origins but also to only one class 1 termi-
nation factor being present in eukaryotes, that should 
not only recognize the stop codons UAG, UAA, and 
UGA but also distinguish them from similar codons, es-
pecially the UGG codon (see reviews by Ehrenberg and 
Tenson, 2002; Kisselev et al., 2003; Nakamura and Ito, 
2003). Such features of eukaryotic translation termina-
tion could require an additional step provided by eRF3.
3. Termination factor eRF3
3.1. STRUCTURE OF YEAST eRF3
The eRF3 proteins of most eukaryotes, except for some 
protozoa, have a three-domain structure (see review by 
Inge-Vechtomov et al., 2003). In S. cerevisiae, the eRF3 is 
encoded by the SUP35 gene (Zhouravleva et al., 1995), 
which is an essential gene (Wilson and Culbertson, 
1988; Grentzmann et al., 1994; Mikuni et al., 1994). The 
N-domain of yeast Sup35  was shown not to be neces-
sary for the viability of the cell (Ter-Avanesyan et al., 
1993). Interestingly, this domain (named also PFD  — 
prion-forming domain) is responsible for the possibility 
of Sup35 prionization with the formation of the [PSI+] 
determinant (Ter-Avanesyan et al., 1994; Derkatch et al., 
1996; Paushkin et al., 1996). In the N-domain, two re-
gions may be identified: a region rich in Q and N (within 
1–40 amino acid residues) and a region of oligopeptide 
repeats (amino acid residues 41–97) containing five full 
PQGGYQ(Q)QYN repeats from nine amino acids and 
one partial repeat, containing four amino acids PQGG 
(Kushnirov et al., 1988) (Fig. 1A). The N-domain of the 
eRF3 family proteins is highly variable, with its amino 
acid sequence differing even in closely related species.
The Sup35  M-domain is enriched with charged 
amino acids and is involved in maintaining prion in a 
series of cell divisions. A short section from 129–148 aa 
is involved in the interaction with Hsp104  and stimu-
lates the ability of the chaperone to break down [PSI+] 
fibrils. Despite N- and M-domains being nonessential 
for Sup35 activity, their conservation suggests them to 
be a two-component functional unit, the critical role of 
which remains still unexplored. NM-domain forms re-
versible pH dependent biomolecular condensates (Fran-
zmann et al., 2018).
The C-terminal domain of the Sup35  protein is 
necessary and sufficient to participate in translation ter-
mination (Ter-Avanesyan et al., 1993). It contains GTP-
binding domains (Kushnirov et al., 1987; Hoshino et al., 
1998) and an eRF1-binding site (Paushkin et al., 1997; 
Ito et al., 1998; Ebihara and Nakamura, 1999; Merkulova 
et al., 1999).
3.2. SUPPRESSOR MUTATIONS IN THE SUP35 GENE
A dysfunction of Sup35  may account for a suppressor 
effect. Therefore, studying suppressor mutations may 
provide insight into the role of Sup35 in the translation 
termination process. When selecting mutations in the 
SUP35  gene by simultaneous reversion of the ade1-14 
(TGA) and his7-1 (TAA) mutations, 48 sup35 mutations 
were obtained (Chabelskaya et al., 2004). After analyz-
ing the content of Sup35 protein in these mutants, it was 
shown that in 32 of them, the amount of Sup35 did not 
differ from the strain carrying the wild-type SUP35 al-
lele, while a third of the strains (16 mutants) had a lower 
content of Sup35  protein compared with the original 
strain. 15 mutants were selected to be sequenced, with 
five having the same level of the full-length Sup35 pro-
tein as in the wild type and 10  revealing a reduced 
amount of the full-length Sup35  protein (Chabelskaya 
et al., 2004) (Table 1 and Fig. 1B, C). The molecular na-
ture of these mutations and their comparison with those 
described in the literature is discussed in the following 
sections. 
3.2.1. Nonsense mutations in the SUP35 gene
Among ten sup35  nonsense mutations characterized, 
seven are localized in the first third of the SUP35 gene, 
encoding the NM-domain of eRF3 (aa 1-253) (Fig. 1B).
Such an uneven distribution of nonsense mutations can 
be accounted for by an increased codon content, with a 
single substitution capable of resulting in a stop codon. 
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The SUP35 gene region encoding the NM-domain does 
contain 48 % of such codons compared with 33 % in the 
region encoding the C-domain of eRF3 and with 34 % in 
the entire yeast genome (Table 2). The absence of muta-
tions resulting in the TGA stop codon among the sup35-
n mutations can be explained by the reduced content 
of “potential” UGA codons (codons, single mutations 
which can lead to the appearance of the UGA codon). 
The SUP35 gene sequence does contain 10 % of such co-
dons, compared with 39 % and 51 % for potential codons 
UAG and UAA, respectively (Table 2). These data cor-
relate with the number of isolated mutations containing 
TAG (4 mutations) and TAA (6 mutations) (Table 3). 
It is worth noting that in the screening for Ade+ re-
vertants twelve sup35-n mutations were isolated, with 
six being TAG mutations and the rest evenly distributed 
between TAA and TGA mutations (Bradley et al., 2003). 
The differences in the ratios of the types of sup35-n mu-
tations can be explained by the differences in the mutant 
selection methods. 
3.2.2. Missense mutations in the SUP35 gene
The finding that all missense mutations isolated from 
different strains are localized in the C-terminal domain 
of eRF3 (aa 254-685) (Fig. 1C, Fig. 2 and Table 1) con-
Table 1. The mutations in the SUP35 gene, described in different works.  
X means substitution of amino acid to stop codon; † indicates the lethality of mutation
Method of selection Type of mutation Nucleotide changes Amino acid changes Reference 
UV-mutagenesis (strain SL183-
21C)
Nonsense T229A L110X Zhou et al., 1999
Suppression of his7-1(UAA) and 
trp1-289 (UAG) (strain 33G-D373)
Nonsense C1264T Q422X Cosson et al., 
2002
Suppression of ade1-14(UGA) his7-
1(UAA) and lys2-87 (UGA) (strain 
2V-P3982)
Missense G1087A; C1133T; G1237A; 
C1724A
D363N; T378I; V413L; P575H Volkov et al., 
2002
Suppression of ade1–14 (UGA) 
(strain 74-D694)
Missense G959T; A1052G; G1070A; 
G1256A; G1429T; A1607C; 
T1957C
R320I; Y351C; G357D; R419H; D477Y; 
N536T; C653R
Bradley et al., 
2003
Nonsense C64T; C147G; C211T; C214T; 
G229T; G334T; G514T (two 
times); G553T; C629A; C668G; 
G1609
Q22X; Y49X; Q71X; Q72X; G77X; 
G112X; E172X (two times); E185X; 
S210X; S223X, E537X
Suppression of ade1-14(UGA) and 
his7-1(UAA) (strain 1B-D1606)
Missense C1115T; G1697A; G1808T; 
G1094T/G1675A; 
R372K; G566N; M603K; G365V/
E559K 
Chabelskaya et 
al., 2004
Nonsense C166T; C214T; A304T(two times); 
C388T; G541T; G586T; C724T; 
C1264T; A1546T; C1984T
Q56X; Q72X; K102X (two times); 
Q129X; E181X; E197X; Q242X; 
Q422X; K516X; Q631X
Duplication 18 bp duplication (begins at 
nucleotide 1217) 
additional 6 aa (begins at aa 305) 
Mutation in 
promoter
G(-183)T no Matveenko et al., 
2019
Suppression of lys9-A21 (UAA) and 
his7-1(UAA) (strain 33G-D373)
Missense A1234C; G1939A T412P; E647K Our unpublished 
data
Nonsense C388T Q129X
Site directed mutagenesis Missense T806G; A1043T; U/C1044G/A; 
A1999G; GAU1225UGG; A1255G
V269G†; H348L†; H348Q; K407E†; 
D409W†; R419G
Salas-Marco and 
Bedwell, 2004
PCR mutagenesis Missense A1219T; G1227A N406I; D409N Kobayashi et al., 
2004
Suppression of ade1-14(UGA) his7-
1(UAA) (strain SUP35C-2V-P3982)
Missense C1157T; G1268A (two times); 
C1724A
T386I; C423Y (two times); P575H Volkov et al., 
2007
Suppression of ade1-14(UGA) his7-
1(UAA) (strain pRSU1C-16AD1608)
Missense T1018C; T1100C; C1235T/
C1236T 
Y340H; L367S; T412I
Site directed mutagenesis Missense A1021G; AC1021GA T341A; T341D† Fabret et al., 
2008 
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firms numerous data on the role of this domain in trans-
lation termination. 
The suppressor phenotype of isolated missense 
mutations cannot be explained by a reduced amount 
of eRF3 or the inability of mutant eRF3 to interact with 
eRF1. These mutations may affect the interaction of 
eRF3 with other proteins or the ribosome. 
All missense mutations obtained result in amino 
acid substitutions that are conservative between S. cere-
visiae and S. pombe eRF3. The exception was one of the 
substitutions in the case of the double sup35-233 muta-
tion (G365V; E559K): N residue was substituted for E 
residue in the S. pombe eRF3  in the homologous posi-
tion, making it possible to arrange the corresponding 
amino acid substitutions in the tertiary structure of the 
C-terminal domain of S. pombe eRF3 (Kong et al., 2004). 
The sup35-228  mutation results in arginine being 
replaced with lysine at position 372. While being very 
similar chemically, these two amino acids differ in their 
methylation capacity. A number of studies have shown 
a simple replacement of arginine with methylated lysine 
to result in a defective protein, with developmental dis-
orders of transgenic tobacco plants as a result of a muta-
tion in the calmodulin gene (Roberts et al., 1992) and a 
sharp decrease in RNase activity in the case of human 
mutant angiogenin (Shapiro et al., 1989).
It should be noted that about half of the sup35 mu-
tations reported in the works of different authors are lo-
cated either in the SUP35 regions encoding the GTPase 
domains of eRF3 or in the immediate vicinity of these 
sites (Fig. 1C, Table 1). Interestingly, the phenotypic 
manifestation of mutations located in the C-terminal 
domain of eRF3 may be influenced by the presence of 
the N-terminal domain of eRF3  (Volkov et al., 2007). 
The same mutations obtained on the background of a 
full-sized or truncated SUP35 had a different phenotypic 
manifestation (Volkov et al., 2007). The interaction of 
this site with the mutant C-terminal domain may reduce 
the GTPase activity of eRF3, resulting in the suppression 
efficiency increase.
The nature of the suppression was investigated in 
details in two mutants in the GTPase domain of yeast 
eRF3 (Salas-Marco and Bedwell, 2004), by studying the 
mutants of eRF3  with impaired hydrolysis of GTP. If 
the functions of eRF3  coincide with those of RF3, the 
eRF3 mutations leading to the nucleotide exchange rate 
decrease should also slow down the release of eRF1 from 
the termination complex. This, in turn, should lead to a 
decrease in the pool of eRF1 available for subsequent ter-
mination events. At the same time, mutations that dam-
age the GTP hydrolysis rate should be defective in the 
dissociation of eRF3  from the ribosomes. In this case, 
the pool of free eRF3 should decrease, thus decreasing 
eRF1 recycling. In the work concerned, six sup35 mu-
tations (V269G, H348L, H348Q, K407E, D409W, and 
Table 2. The distribution of potential stop codons in 
the SUP35 and SUP45 genes. The program “Countcodon” 
(http://www.kazusa.or.jp/codon / countcodon.html)  
was used to calculate the content of different codons
Gene
Domain 
(codons 
number)
The number of potential stop 
codons (%):
UAA UAG UGA All
SUP35 N (123) 29.7 17.9 3.6 51.2
M (139) 22.6 21.6 0.4 44.6
C (433) 16.2 12.1 4.7 33.0
N+M (252) 26.1 20.1 2.0 48.2
N+M+C (685) 19.8(51 %)
15.1
(39 %)
3.7
(10 %)
38.6
(100 %)
SUP45 N (132) 19.9 14.2 4.8 39.1
M (120) 14.2 8.7 7.9 30.8
C (185) 22.7 12.4  3.2 38.3
N+M+C (437) 19.7(53 %)
12.0
(33 %)
5.2
(14 %)
36.9
(100 %)
Total in the genome 
of S. cerevisiae 
14.5
(43 %)
12.5
(37 %)
7.1
(20 %)
34.1
(100 %)
Table 3. Nucleotide context surrounding sup45 and 
sup35 nonsense mutations
Mutation
Amino 
acid 
position
Nucleotide context surrounding 
preliminary termination codon*:  
5’ stop 3’
sup45-102 Y53 TTA ACA GAT GAA TAА GGT ACT GCC TCG 
sup45-101, 20 E266 AAC CAG GCT ATC ТAA CTT TCT GCC GAA 
sup45-104 L283 CAA GAA AAG AAA TАA TTG GAG GCA TAT 
sup45-105 E385 GGT GCT ACC TTG ТAA TTC ATC ACA GAC 
sup45-13 E266 GCT ACC GGC CAA ТAA ATG GAC GTT GTC 
sup35-240 Q56 GGT TCT GGG TAC TAA CAA GGT GGC CAA
sup35-218 E181 GCT GAA ACC AAA TAA CCA ACT AAA GAG
sup35-13, 215 K102 CGT GGA AAT TAC TAA AAC TTC AAC TAC
sup35-231 Q631 CAA GAT TAC CCT TAA TTA GGT AGA TTC
sup35-21 Q422 GAA CGT TAC GAC TAA TGT GTG AGT AAT
sup35-74 Q129 TTG AAC GAC TTT TAA AAG CAA CAA AAG
sup35-201 K516 GGT CAT ATC AAA TAG GGT CAA TCC ACC
sup35-260 Q242 TTG ATC AAG GAA TAG GAA GAA GAA GTG
sup35-244 E197 CCA GTT AAA AAG TAG GAG AAA CCA GTC
sup35-203 Q72 GGT TAC CAG CAA TAG TAT AAT CCT CAA
sup45-107 L317 GCA GTC GAA AAA TGA ATT GTT TTC GAA
* CAA codons are underlined, adenines preceding nonsense 
mutations and promoting the translation of stop codons in yeast cells 
(Tork et al., 2004) are highlighted in yellow. Nucleotides at position 
+4, contributing to and inhibiting the translation of the stop codon 
(Bonetti et al., 1995) are highlighted in blue and green, respectively.
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R419G) were obtained using site-specific mutagenesis. 
Only two of the six mutant proteins (eRF3-H348Q and 
eRF3-R419G) proved to be able to maintain the viability 
of yeast cells, although their presence resulted in a de-
crease in the growth rate. H348Q and R419G mutations, 
decreasing the rate of GTP hydrolysis, resulted in signif-
icant impairment of translation termination only on the 
UGAN stop codons (the stop codon translation level, 
being a significant one, increased by 3.7–16.8 times de-
pending on the stop codon). At the same time, most of 
UAGN or UAAN codons maintained their termination 
codon properties in the presence of eRF3-H348Q or 
eRF3-R419G mutant proteins. The only exceptions were 
the tetranucleotides UAGC and UAAC, with the transla-
tion of the stop codon being 3.2–4.4 times higher than 
that of the wild-type eRF3  (Salas-Marco and Bedwell, 
2004). Thus, the detection of eRF3 mutations that dis-
rupt both GTPase activity and the recognition of specific 
stop signals provides evidence for eRF3  functions not 
to be limited to the simple recycling of eRF1. N406I or 
D409N substitutions in GTP-binding motif NKXD re-
duced affinity for GTP and eRF1-eRF3 association was 
markedly impaired (Kobayashi et al., 2004). 
A potential phosphorylation site has been identified 
in the C-terminal Sup35 domain. It was found that the 
threonine residue at position 341 can be phosphorylated 
by protein kinase A in vitro. Provided this residue is re-
placed by asparagine (constitutive phosphorylation) or 
alanine (lack of phosphorylation), the translation termi-
nation accuracy is reduced by 4 and 2 times compared to 
wild protein type, respectively, with a disruption of the 
interaction of Sup35 and Sup45 and a decrease in GT-
Pase activity. It is noteworthy that unlike T341A, T341D 
reduced cell viability whereas, in the absence of the N-
domain, both mutant proteins were able to compensate 
for the disruption of the wild-type allele (Fabret et al., 
2008). In subsequent work, it was shown that the T341D 
replacement causes synthetic lethality in combination 
with a prion [PSI+], and the T341A mutation results in 
a weakening of [PSI+]. Thus, the authors showed the in-
fluence of the C-domain on the [PSI+] properties and its 
role in the formation of fibrils (Kabani et al., 2011). 
3.2.3. Other mutations in the SUP35 gene
The sup35-217 mutation results in the duplication of six 
amino acid residues (VNKMDL) (Table 1), forming one 
of the GTP-binding motifs (N406K407D409) (Kong et al., 
2004). The mutation sup35-50 (T412P) is localized in the 
same region. It is possible that these mutations disrupt 
the GTPase activity of eRF3, resulting in suppression. 
Mutations in the GTP-binding motif (N153KMD156) of 
the yeast translation elongation factor eEF1A are known 
to cause suppression of all three stop codons (Carr-
Schmid et al., 1999).
In the case of sup35-222  mutation which is char-
acterized by omnipotent nonsense suppression and re-
duced levels of Sup35 and Sup45 proteins, we could not 
detect any change in the coding region of SUP35 (Cha-
belskaya et al., 2004). Using whole-genome sequencing 
of the sup35-222  mutant strain one single-nucleotide 
variation was found 183 bp upstream of the SUP35 cod-
ing sequence (Table 1). It was suggested that this sub-
stitution destroys potential Abf1-binding site in the 
SUP35 promoter (Matveenko et al., 2019).
Sequence polymorphism of the SUP35 gene of the 
Peterhof genetic line (PGL) and the sequence presented 
in GenBank (S288C) was detected. All polymorphic sites 
were located in the non-conserved NM-domain and did 
not have their own phenotypic manifestation (Volkov et 
al., 2000).
4. Termination factor eRF1
4.1. eRF1 STRUCTURE
The structure and sequence of eRF1 are highly conserva-
tive (Frolova et al., 1994) although some organisms have 
several eRF1 paralogs that may vary in specificity of stop 
codon recognition (Liang et al., 2001; Chapman and 
Brown, 2004; Kim et al., 2005; Atkinson et al., 2008; Kim 
et al., 2008). The eRF1 protein consists of three domains: 
N, M, and C (Fig. 2, 3A).
The TASNIKS and YxCxxxF motifs, which are like-
ly to play the role of specific “protein anticodons”, are 
required for the N-terminal domain to recognize a stop 
codon (Song et al., 2000; Frolova et al., 2002; Salas-Mar-
co and Bedwell, 2004; 2006; Fan-Minogue et al., 2008; 
Cheng et al., 2009). The same domain is required for 
binding to the ribosome (Chavatte et al., 2001). The cen-
tral M-domain with a conservative GGQ motif provides 
peptidyl-tRNA hydrolysis (Frolova et al., 1999; Seit-Ne-
bi et al., 2001). The C-terminal region of eRF1 contain-
ing the amino acid sequence GFGGIG (G/A) XLRY is 
responsible for the eRF1–eRF3 binding (Eurwilaichitr et 
al., 1999; Merkulova et al., 1999).
X-ray analysis of human eRF1 and S. pombe (Song 
et al., 2000; Cheng et al., 2009) has shown the eRF1 mol-
ecule to resemble the tRNA molecule in three-dimen-
sional structure, confirming the hypothesis of molecular 
mimicry proposed earlier for prokaryotic release factors 
(Ito et al., 1996).
4.2. SUPPRESSOR MUTATIONS IN THE SUP45 GENE
A specific feature of class-1 release factors is their ability 
to recognize stop codons. Disruption of this function can 
also appear in the form of a suppressor effect, suggesting 
that the study of suppressor mutations can provide infor-
mation on the mechanism of recognition of stop codons 
by class-1  termination factors. The molecular mimicry 
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hypothesis implies that class-1  release factors mimick-
ing the structure of tRNA include “peptide anticodon” 
responsible for recognition of the stop codon and tRNA 
corresponding to the anticodon (Ito et al., 1996).
The selection of mutations in the SUP45 gene was 
performed by simultaneous reversion of nonsense TAA 
mutations located in two different genes (HIS7  and 
LYS9) (Moskalenko et al., 2003). To select the mutations, 
two different strains were used. The selection system 
specificity was associated with the search for such muta-
tions in the SUP45 gene that would disrupt the interac-
tion of eRF1 with only one of the three stop codons (in 
this case, the UAA). Sequencing the resulting mutations 
would allow identification of the eRF1  region respon-
sible for recognizing nonsense codons.
4.2.1. Nonsense mutations in the SUP45 gene
We have characterized six sup45  nonsense mutations, 
with two of them located in the region of the SUP45 gene 
encoding the NM-domains of eRF1  (Table 4, Fig. 3B). 
Three sup45-n mutations are located in the last third 
of the SUP45  gene, encoding the C-terminal domain 
of eRF1. Figure 3B shows that most of the nonsense 
Fig. 2. Suppressor missense mutations in SUP45 and SUP35 genes studied in our laboratory. 
All the mutations were denoted on 3D model of eRF1-eRF3C-GDPNP protein complex of S. cerevisiae (Preis et al., 2014). eRF1 (containing 
N, M and C domains) and eRF3C (corresponding only C-terminal part of eRF3) are shown in aquamarine and yellow orange colors, re-
spectively. Mutations in SUP45 gene that were also obtained in different works (see Table 4) are shown in red spheres (“hot spot”); while 
mutations obtained only once are shown in raspberry spheres. All single mutations sup35 obtained in our laboratory are shown in green 
spheres (see Table 1). The NIKS motif, the YxCxxxF motif and the GGQ motif of eRF1 are shown in purple ribbons. Nonhydrolyzable GTP 
analog guanylyl imidodiphosphate (GDPNP) is shown in blue sticks. The figure is generated by PyMOL (https://www.pymol.org/pymol).
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sup45 mutations, isolated by various authors, are located 
precisely in the last third of the SUP45 gene.
4.2.2. Missense mutations in SUP45 gene
All the sup45 missense mutations, isolated on strain 1B-
D1606, are localized in the N-terminal eRF1  domain 
(Fig. 3C), confirming numerous data on the role of this 
domain in stop codon recognition. Five out of eleven 
isolated sup45-m missense mutations result in methio-
nine being substituted by isoleucine in the 48 position. 
That this region of the eRF1 protein is a “hot spot” con-
firms the fact that similar mutations were obtained by 
other authors by using different approaches for isolat-
ing mutations in the SUP45 gene. It should be noted that 
in our work, the unipotent phenotype with growth on 
Fig. 3. The mutations obtained in the SUP45 gene. 
A. Sup45p consists of three domains: N, M and C (Kisselev et al., 2003). N-domain includes two conservative release activity motives: 
TASNIKS and YxCxxF, which are required for stop codon recognition. M-domain contains conservative GGQ-motif performing pepti-
dyl-tRNA hydrolysis. C-domain contains two eRF3 binding sites, the last one stimulates GTPase activity of eRF3 (Eurwilaichitr et al., 1999; 
Merkulova et al., 1999). B. Nonsense mutations in SUP45 gene obtained in our laboratory (Moskalenko et al., 2003). Numbers above 
Sup45 protein scheme correspond to numbers of the sup45 mutations. PTC (premature termination codon) positions match to the aa 
length of truncated proteins formed in the case of translation termination on the sup45 mutations. C. Suppressor missense mutations 
in SUP45 gene obtained in different laboratories (Breining and Piepersberg, 1986; Mironova et al. 1995; Stansfield et al. 1996; Bertram 
et al. 2000; Bradley et al 2003; Moskalenko et al., 2004; Valouev et al. 2004). Alignment of S. cerevisiae and H. sapiens eRF1s is shown. The 
triangle signs correspond single missense mutations (stacks of them correspond to hotspot mutation sites). Arrows below N, M or C 
mean the start of corresponding domain of Sup45. TASNIKS, YxCxxF and GGQ-motives are framed; eRF3 binding sites are underlined.
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Table 4. Mutations in the SUP45 gene, described in different works.  
X means substitution of amino acid to stop codon; † indicate lethality of the mutation; * only single mutations are listed 
Method of selection Type of mutation Nucleotide changes Amino acid changes Reference 
Suppression of ade1–14 (UGA) 
and sensitivity to paromomycin 
(strain 7B-D244)
Missense T101C L34S Breining and 
Piepersberg, 
1986
Suppression of ade1-14(UGA) and 
his7-1(UAA) (strain P3990)
Missense C193T R65C Mironova et al., 
1995
EMS mutagenesis (strain 
BSC483/la)
Nonsense C136T; C175T; C1078T; A1231T Q46X; Q359X; Q360X; K411X Stansfield et al., 
1996
Allosuppressor of SUQ5 (strain 
MT552)
Missense T665G I222S Stansfield et al., 
1995b
Suppression of ade1–14 (UGA) 
(strain IS31D7b/ 1c) or ade2-
1(UAA) (strain TGB7a/5b)
Missense A94T; C113T; G144A; T203C; A219T; A320G; 
N367G; A386G; G1282C
I32F; P38L; M48I; V68I; V68A; 
S74F; D110G; L123V; H129R; 
E428Q
Bertram et al., 
2000
Nonsense C1243T Q415X
Suppression of ade1–14 (UGA) 
(strain 74-D694)
Missense G144T; G187T; T188A; G659A; G757T; 
T824A; A1229C
M48I; V63F; V63D; G220D; 
V253F; V275D; Y410S
Bradley et al., 
2003
Nonsense G366A; G1115A; G1243T E366X; W372X; E414X
Suppression of lys9-A21(UAA) and 
his7-1(UAA) (strain 33G-D373)
Nonsense G796Т E266X Our unpublished 
data
Missense G528T; С777А (two times); A1229G (three 
times)
K176N; N259K (two times); 
Y410C (three times)
Moskalenko et 
al., 2004
Suppression of ade1–14 (UGA) 
and his7-1(UAA) (strain 2V-P3982)
Missense T62C (two times); C113T; A122C (two 
times); G144T; G240C
L21S (two times); P38L; Q41P 
(two times); M48I; K80N
Suppression of lys9-A21(UAA) and 
his7-1(UAA) (strain 1B-D1606)
Missense T62C; G144T (five times); G185C (two 
times); C209T
L21S; M48I (five times); R62T 
(two times); S70F
Nonsense T159А; G796Т; T848А; Т950G; G1153T Y53X; E266X; L283X; L317X; 
E385X 
Moskalenko et 
al., 2003
Spontaneous mutagenesis 
(strain 33G-D373)
Missense T67C; G228C/C229T S30P; Q76H/Q77X Valouev et al., 
2004
Spontaneous cryptic mutations 
(strains 4V-P4482 and 10-2V-
P3982)
Missense G1199T
C224T
G400V
T75I
Aksenova et al., 
2006
Site directed mutagenesis Missense T1261G; T1294G; T1261G/T1294G; 
TC1261GA; TC1294GA; TC1261GA/TC1294GA
S421A; S432A; S421A/S432A; 
S421D; S432D; S421D/S432D 
Kallmeyer et al., 
2006
Site directed mutagenesis Nonsense С951Т L317X Zhouravleva et 
al., 2007
Site directed mutagenesis Missense T544G; T544G/G(A)546C(T) Q182E; Q182N Studte et al., 
2008
Site directed mutagenesis Missense A1229C Y410S Akhmaloka et 
al., 2008
Site directed mutagenesis Nonsense С228Т; С726Т Q76Х, R242Х Kiktev et al., 
2009
Missense TA157GG; A1154G; A1155T Y53Q; E385Q; E385Y
PCR mutagenesis Missense A79T; G151A; T174A; C226A; A227G; 
A257G; G310A; T325C; A641G; A1079T; 
A1079G
N27Y; D51N; N58K; Q76K; 
Q76R; K87E; E104K; F109L; 
D214G; E360V; E360G
*Hatin et al., 
2009
PCR mutagenesis Missense CT148GC; A158N; G163A†; A165G; 
AA174GT; AA180GT†; AG183GT; AG186GT; 
T322A; N523F; AA525GT†; AA528GT†; 
G541T†; G544T†; A886G; A915G; A1071G; 
A1164G; T1204A; A1231T
L49A; E52A; G54D†; T55A; 
N58A; K60A †; S61A; R62A; 
V107D; P174Q; K175A †; 
K176A †; G180A †; G181A †; 
T295A; T305A; T357A; T388A; 
F401Y; Y410F
Merritt et al., 
2010
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selective media characterized both the sup45-113 muta-
tion (M48I) and the sup45-115 mutation (S70F). Muta-
tion M48I also was described as unipotent by Bertram et 
al. (2000). At the same time, this mutation is reported as 
omnipotent on a different genotypic background (Mos-
kalenko et al., 2004). 
We compared the distribution of the amino acid 
substitutions in the eRF1 protein described in the litera-
ture that were caused by missense mutations. As can be 
seen from Figure 3C and Table 4, the N-domain posi-
tions, in which missense mutations in the SUP45 gene 
are found with different selection methods, are the same 
for many authors. 
We have found two mutations (S70F and R62T) in 
N-domain of Sup45 that has not been described previ-
ously in the literature. A substitution identified by se-
quencing the first mutant SUP45 allele (L34S) (Breining 
and Piepersberg, 1986) was in the same region. Also, 
one more mutant (sup45-3  containing R65C) was de-
scribed in our laboratory earlier (Mironova et al., 1995). 
It makes it possible to conclude that there are only a few 
positions in the eRF1 protein where substitutions are not 
lethal and lead to nonsense suppression. 
The remaining six mutations selected in our work 
on strain 33G-D373 result in amino acid substitutions 
in three sites, with one being in the central part of the 
yeast eRF1 (position 176), and two at the C-end of the 
molecule (position 259 and 410). Position 176 is close to 
one of the putative eRF1 interaction sites with eRF3 in 
S. pombe (amino acid residues 187–247 (Ito et al., 1998). 
According to our data, a mutation in this position dis-
rupts the interaction of eRF1 and eRF3 in the two-hybrid 
system, possibly leading to the effect of nonsense sup-
pression. Since the C-terminal amino acid residues of 
eRF1 are actively involved in the interaction with eRF3, 
the effect of mutations at positions 259  and 410  may 
also be associated with a disruption of this interaction. 
It was shown that substitution Y410S decreased bind-
ing affinity of eRF1 to eRF3 up to 20 % of the wild type 
(Akhmaloka et al., 2008) 
Thus, the distribution pattern of the mutations 
studied allows one to conclude that most of the missense 
mutations in the SUP45 gene, selected by the nonsense 
suppression effect, result in amino acid substitutions in 
the N-terminal part of the eRF1  molecule, limited by 
21–80 positions. Mutations selected by the suppression 
effect of a nonsense mutation of the same type (TAA) 
can result in aa substitutions in different parts of the 
molecule, or they represent nonsense mutations in the 
SUP45  gene (Moskalenko et al., 2003). However, even 
in this variant of selection, most missense mutations af-
fect the same positions in the eRF1 protein as mutations 
selected by the “classical” method. It is also significant 
that none of the missense mutations studied reduced the 
amount of eRF1 protein. 
It is interesting to compare our data with the data 
obtained in the Stansfield laboratory (Bertram et al., 
2000), where the mutants for the SUP45 gene were se-
lected by using a library of mutagenized plasmids carry-
ing the SUP45 gene. The goal of this work was to identify 
the mutant SUP45 alleles exhibiting a “unipotent” sup-
pressor effect that suppresses only one type of nonsense 
mutations. However, although the mutations obtained 
had different codon specificity at the phenotypic level, 
it was found that in their presence, all three stop codons 
were actually read, albeit with different efficiencies (Ber-
tram et al., 2000). Most of the mutations obtained in this 
work also affect the N-terminal part of the protein (posi-
tions 32, 38, 48, 68, 74). At the same time, some of them 
affected the same positions in the protein as the muta-
tions studied by us (positions 38 and 48). In addition, 
three amino acid substitutions were located somewhat 
to the right of the site marked in our work (positions 
110, 123, 129), with one more substitution located at the 
C-end of the molecule (position 428).
This work focused mainly on mutations affect-
ing the N-terminal part of the molecule. In addition to 
our data suggesting that the mutations in question did 
not affect the interaction with the eRF3 protein, it was 
shown that these mutants were not influenced by the 
binding to the ribosome. Thus, the most likely function 
impaired by amino acid substitutions in the N-terminal 
part of the eRF1 protein is the interaction of eRF1 with 
stop codons. 
The involvement of the N-terminal domain in rec-
ognition of a stop codon was shown in vivo (Bertram 
et al., 2000) since mutations in this region resulted in a 
change in the specificity of stop codon recognition by 
the eRF1  protein. Genetic screening of mutants char-
acterized by a unipotent suppressor phenotype (that 
is, leading to the suppression of only one stop codon) 
revealed a series of missense mutations (Bertram et 
al., 2000) (Fig. 3C, Table 4). Most of them were located 
in the gap between the two α-helices and the opposite 
β-layer of the N-domain eRF1. It is hypothesized that it 
is these structures that form the surface of eRF1 involved 
in the interaction with mRNA. With all isolated mutants 
revealing a weak omnipotent suppressor phenotype, a 
hypothesis was put forward that stop codon decoding in 
eukaryotes is an integral process—that is, the recogni-
tion of a single nonsense codon cannot be completely 
separated from the recognition of other termination co-
dons. This hypothesis suggests that stop codon decoding 
in eukaryotes is more complex and therefore different 
from sense codon decoding using tRNA (Bertram et al., 
2000).
Additional data concerning the molecular mecha-
nisms involved in the discrimination of stop codons were 
obtained in experiments using proteins of the eRF1 fam-
ily from organisms using the UAG codon or the UAA 
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and UAG codons as sense codons (see the review by 
Lozupone et al., 2001). It is evident that eRF1  should 
no longer recognize UAG (or UAA and UAG) in these 
organisms as translation termination signals. In this re-
gard, it was suggested that amino acid residues that de-
termine the specificity of eRF1 to a specific stop codon 
could be identified by comparing the eRF1sequences in 
organisms with non-standard genetic code with organ-
isms that have a universal genetic code (Karamyshev 
et al., 1999). The comparison of sequences did allow a 
number of hypotheses explaining the decoding process 
to be formulated (Inagaki and Doolittle, 2001; Lozupone 
et al., 2001; Muramatsu et al., 2001; Inagaki et al., 2002). 
Unfortunately, these models were not confirmed by ex-
periment, with most of the experiments making it pos-
sible to establish that the recognition of a stop codon is 
not a linear sequence of amino acid residues eRF1, but 
more complex structural motif (s) (Ito et al., 2002; Seit-
Nebi et al., 2002; Chavatte et al., 2003; Salas-Marco et 
al., 2006). 
A large collection of point mutations in yeast 
SUP45  was obtained and characterized (Hatin et al., 
2009). Among them were mutations that significantly 
increased translation termination efficiency, some of 
which are listed in Table 4. However, most of the mu-
tants contained two or three aa changes (Hatin et al., 
2009). From twenty new sup45  mutants six were invi-
able (Table 4) (Merritt et al., 2010). A large number of 
interesting conclusions came from this work, includ-
ing strain-specific differences in the stop codon read-
though, and between in vivo and in vitro experiments. 
Extensive characterization of sup45  mutants from dif-
ferent collections as well as new ones allowed authors 
to show that various phenotypes associated with these 
mutants are independent of defects in translation termi-
nation (Merritt et al., 2010). 
Using site-directed mutagenesis, Sup45 phosphory-
lation sites were identified (Kallmeyer et al., 2006), and 
the effect of Sup45 methylation on translation termina-
tion accuracy was shown (Studte et al., 2008).
5. Appearance of nonsense mutations in 
SUP45 and SUP35 genes
In our work, nonsense mutations in the essential 
SUP45 and SUP35 genes were shown for the first time 
not to cause lethality in the absence of suppressor 
tRNA. Currently, several processes are known that can 
overcome the negative effect associated with the pres-
ence of nonsense codons. In particular, the presence of 
mutant (and in some cases non-mutant) tRNA in the cell 
results in the suppression of stop codons (see the review 
by Beier and Grimm, 2001). The so-called “weak” ter-
mination context and/or the RNA secondary structure 
specificity can also result in stop codon translation (see 
review Bertram et al., 2001). In our work it was shown 
that viability of sup45  nonsense mutants is supported 
by diverse mechanisms that control the final amount of 
functional Sup45 in cells (Kiktev et al., 2009).
Many laboratory strains, as well as natural popula-
tions of E. coli, contain suppressor tRNAUAG (Tate et al., 
1996). The mutation rate in at least some tRNA genes 
is known to be significantly increased (Ito-Harashima 
et al., 2002). It is highly unlikely that the initial strains 
33G-D373 and 1B-D1606 used in our work contain mu-
tant suppressor tRNA. Firstly, such suppressors are usu-
ally codon-specific, and their presence would result in 
the appearance of nonsense sup45 or sup35 mutations of 
only one type (for example, TAA). In our work, muta-
tions of different types were isolated: (TAA) and (TGA), 
in the case of sup45-n, and (TAA) and (TAG) for sup35-
n. Secondly, all the sup45-n and sup35-n mutations de-
scribed in our work are recessive, while mutations in the 
tRNA genes are usually dominant. All sup35-n transfor-
mants selected during plasmid shuffle experiments and 
containing nonsense sup35 mutations on the plasmid re-
tained their recessive suppressor phenotype, while in the 
case of additional mutations this effect should be domi-
nant. Moreover, it is known that suppressor mutations in 
tRNA genes are generally incompatible with sup35 and 
sup45 mutations (Song and Liebman, 1985). Thirdly, the 
parent strains, as well as the strains used to assess the 
viability of the sup45-n and sup35-n mutations, did not 
possess the tested in vitro suppressor activity. In strains 
1A-D1628 and 16A-D1608 used in plasmid substitution 
experiments, no suppression of ade1-14  (TGA), his7-
1 (TAA), trp1-289 (TAG) and lys9-A21 (TAA) mutations 
was found. In addition, the sequenced genome of strain 
S288C, the isogenic derivatives of which were used in 
plasmid substitution experiments, does not contain mu-
tations in the tRNA genes (Percudani et al., 1997, Droz-
dova et al., 2016). 
Non-lethal nonsense mutations in the SUP35  and 
SUP45 genes were described by other authors (Zhou et 
al., 1999; Bradley et al., 2003), but in those cases, it re-
mained unknown whether the parent strain possessed 
any suppressor activity. The nonsense mutations in the 
SUP45 (sup45-0) gene were also isolated in the presence 
of the SUQ5  mutation, resulting in the appearance of a 
suppressor tRNASer in the cell; but these mutations were 
lethal in the absence of the SUQ5 mutation (Stansfield et 
al., 1996). We have estimated the content of “potential” 
stop codons (codons, single mutations in which can lead 
to the appearance of stop codons) in the SUP45 gene (Ta-
ble 2). In the case of codons, single mutations in which 
can lead to the appearance of two different stop codons 
(for example, replacing a TTA codon in the second po-
sition will result in a TAA codon or TGA), the corre-
sponding frequencies were equally divided between the 
two classes. The data given in Table 2  indicate that po-
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tential stop codons are fairly evenly distributed across the 
SUP45 gene sequence. In the regions encoding the N, M 
and C-domains, such codons account for 39.1 %, 30.8 % 
and 38.3 % of the total number of codons, respectively. 
Thus, the uneven distribution of nonsense muta-
tions in the SUP45 gene cannot be accounted for by the 
increased codon content, a single substitution in which 
can result in the appearance of a stop codon. It is possible 
that the preferred localization of nonsense mutations in 
the region encoding the C-domain is related to the nu-
cleotide context features. The absence of mutations re-
sulting in the appearance of the stop codon UAG among 
the sup45-n mutations can be explained by the specificity 
of selection carried out by the simultaneous reversion of 
two other mutations. At the same time, in the screening 
of Ade+ revertants (a strain containing the ade1-14 mu-
tation (TGA) was used), two sup45-n TAG mutations 
and one TAA were isolated (Bradley et al., 2003). The 
fact that only one of the five sup45-n mutations isolated 
(Moskalenko et al., 2003) caused the appearance of the 
TGA codon can be explained by the reduced content of 
potential UGA codons in the SUP45 gene sequence. In-
deed, the SUP45  gene sequence contains 14 % of such 
codons as compared with 33 % and 53 % for potential 
codons UAG and UAA, respectively (the number of po-
tential stop codons is taken as 100 %) (Table 2).
The termination efficiency is known to depend on 
the local context surrounding the stop codon (see re-
views by Tate and Mannering, 1996; Kisselev and Buck-
ingham, 2000; Bertram et al., 2001). Although the local 
context in yeast and bacteria is different, there is a fairly 
strong correlation between the frequency of a particular 
nucleotide being present at position +4  in the natural 
termination sites and the termination efficiency at the 
corresponding tetranucleotide stop codon (Bonetti et 
al., 1995; Poole et al., 1995). According to these data, 
the relative level of the full-length eRF1 protein corre-
lated with the strength of the translation termination 
signal: in the case of the strongest (UAAG) and weakest 
(UAAC) termination signals, the number of eRF1  was 
8 % and 32 % of the wild-type level, respectively (Mos-
kalenko et al., 2003).
In the case of the UGA codon, the translation ter-
mination efficiency decreases in the order G> U> A> C 
depending on the position (+4) while for the UAG co-
don, this order is different (A> U> C> G) (Bonetti et 
al., 1995). Indeed, the sup45-107  mutation (TGAA) is 
located in a weak terminating context. At the same time, 
the replacement of the TGA codon by TAG in the mu-
tant sup45-107 allele led to a change in the local context 
(TGAA → TAGA) and lethality (Moskalenko, 2003). 
Thus, the sup45-n mutations can be supposed to be lo-
cated in a “weak” terminating context. 
It should be noted that all sup45-0 mutations that 
caused the UAA codon to appear in the presence of 
SUQ5 (Stansfield et al., 1996) were located in a “strong” 
context since purine was in the +4 position of these mu-
tations. However, since one of our viable sup45-n mu-
tants (sup45-13) contained an allele identical to sup45-
18 (Stansfield et al., 1996), the inviability of the sup45-
0 mutants in the absence of SUQ5 cannot be explained 
by the influence of the context. A mathematical model 
predicting the Sup45  translational readthrough nega-
tive feedback loop control was created; this model an-
ticipates that manifestation of sup45-n mutations will 
depend on nucleotide context, as well as on the level of 
tRNA suppression and amount of SUP45 mRNA (Bet-
ney et al., 2012). 
We have not found an apparent correlation between 
the location of the nonsense mutation in the SUP35 gene 
coding sequence and the amount of the full-length 
eRF3 protein. It is known that not only the nucleotide at 
position +4, but also the other nucleotides surrounding 
the stop codon, affect the efficiency of translation termi-
nation (Mottagui-Tabar et al., 1998; Cassan and Rousset, 
2001; Namy et al., 2001; 2002; Liu, 2005). It is assumed 
that this effect is due to the interaction of these mRNA 
sites with various components of the translation appara-
tus (see review by Tate et al., 1996; Bertram et al., 2001). 
We have compared the nucleotide environment of stop 
codons for the nonsense sup45 and sup35 mutations that 
were isolated in our works (Table 3).
Analysis of the nucleotide context revealed that 
among 16 sup45-n and sup35-n mutations, 8 contain ad-
enine at position -1, 12 contain adenine at position -2, 
and 8 contain adenine in both positions. The presence 
of two adenines immediately before the stop codon was 
shown to facilitate translation of the stop codon in yeast 
cells (Tork et al., 2004). Some of the mutations are sur-
rounded by codons CAA, which are known to increase 
the level of suppression (Kopczynski et al., 1992; Bonetti 
et al., 1995). It is possible for all the sup45-n and sup35-n 
mutations to be located in a weak terminating context.
6. Suppression due to prion [PSI+]
Sup35 protein aggregation in a yeast cell leads to the ap-
pearance of a prion [PSI+]. In order to be considered a 
prion, a genetic determinant must satisfy a number of 
genetic criteria (Wickner et al., 1995). One of them is 
the similarity of phenotypes in mutants by the structur-
al gene of the prion and prion-associated phenotypes. 
The main phenotypic manifestation of the [PSI+] fac-
tor is a decreased translation accuracy (see review Cox 
et al., 1988), which is similar to the mutation effect in 
the SUP35 gene, the structural gene of [PSI+]. Different 
strains of [PSI+] exhibit different suppression efficiencies 
(Derkatch et al., 1996) which can vary from 0.2 to 35 % 
(Bidou et al., 2000; True et al., 2000; Uptain et al., 2001; 
Kiktev et al., 2009). Early works argued that the [PSI+] 
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factor does not affect the growth rate of yeast strains 
(see the review by Cox et al., 1988). Studies conducted 
on seven yeast strains using 150 different culture con-
ditions showed that in 50 % of cases [PSI+] did not re-
ally affect growth, while the other cases demonstrated 
both growth inhibition and stimulation in the presence 
of [PSI+] (True et al., 2000). In some cases, the [PSI+] 
factor led to a change in the colony morphology (True 
et al., 2000) and cell sensitivity to paromomycin at 20°C 
(Cosson et al., 2002). A systematic comparison of the 
phenotype of [PSI+] strains with isogenic [psi-] strains, 
as well as isogenic strains carrying the sup35  (C653R) 
mutation, in 70 % of cases, revealed a coincidence of 
[PSI+]-induced phenotypes with phenotypes caused by 
the SUP35 mutation. At the same time, in 30 % of cases, 
such a correlation was not observed (True et al., 2004). 
This fact allowed the authors to suggest that the presence 
of [PSI+] factor in yeast cells can provide them with se-
lective advantages due to the expression of pseudogenes 
or 3’ untranslated RNA under normal conditions (see 
the review by Shorter and Lindquist, 2005). Despite the 
fact that this hypothesis remains to be proved and pro-
vokes active criticism from a number of researchers (see, 
for example, Nakayashiki et al., 2005), it is obvious that 
in some cases the phenotype caused by the presence of 
the factor [PSI+] may differ from the phenotype caused 
by the SUP35 mutations. A possible explanation for such 
differences may be that in the cited work (True et al., 
2004), the phenotypes caused by the presence of [PSI+] 
were compared with phenotypes of only one sup35 mu-
tation. Various sup35 mutations are known to reveal var-
ious manifestations, including thermosensitivity or its 
absence, different suppression efficacy, sensitivity or re-
sistance to benomyl, paromomycin, etc. The reasons for 
these differences are not currently known. At the same 
time, the [PSI+] factor, originally described as the allo-
suppressor SUQ5 (Cox et al., 1988), does not on its own 
suppress all nonsense mutations. Hence, early studies re-
ported [PSI+] not to suppress TAG mutations and most 
TAA mutations (Liebman and Sherman, 1979). It should 
be noted that the quantitative assessment of the sup-
pression effectiveness that showed [PSI+] to suppress all 
three stop codons was carried out on a strain containing 
the SUQ5 mutation (Firoozan et al., 1991). The mutant 
tRNASer resulting from the SUQ5 mutation is known not 
only to suppress the UAA codon but, in the presence of 
the sal4-2 mutation, to have an allosuppressive effect on 
the UAG codon (Stansfield et al., 1995b). The [PSI+] fac-
tor has been reported to suppress mutations in cyc1-72, 
trp5-48, cyc1-179 (TAA) (Liebman and Sherman, 1979), 
met8-1, lys2-A12  (TAG) (Ono et al., 1986; Chernoff et 
al., 1995), lys2-101  (TGA) (Ono et al., 1986), lys2-87, 
ade1-14, thr4-B15 (TGA) (Chernoff et al., 1995), ade1-6, 
leu2-2, his7-1, lys9-A21, ade2-1 (TAA) (Derkatch et al., 
1996). It is difficult to compare the data of various re-
searchers on the specificity of [PSI+]-mediated suppres-
sion due to the differences in the strains used, as well as 
due to different variants of the [PSI+] factor.
Concluding remarks
While the main goal of this review was to summarize 
known data about suppressor mutations isolated in 
SUP35  or SUP45  genes, some other mutations in these 
genes were not discussed. A number of mutations named 
PNM (from “[PSI+] no more”, Doel et al., 1994) have been 
identified in the SUP35 gene, affecting the maintenance of 
the [PSI+] factor. Such mutations are not known for the 
SUP45 gene. A significant amount of antisuppressor muta-
tions was obtained in the SUP45 gene (Hatin et al., 2007), 
only some of them are shown in Table 4. We also did not 
discuss the role of numerous proteins such as ABCE1, 
Dbp5, PABP, Hrp1, Pub1, Upfs and so on that also take 
part in translation termination (see Tieg and Krebber, 
2013; Schuller and Green, 2018 for recent review).
Multiple effects of mutations in the SUP35  and 
SUP45  genes have been revealed, but their origin still 
needs to be clarified. It is possible that not only are the 
SUP35 and SUP45 genes involved in translation, but they 
also participate in the control of other cellular processes. 
However, an alternative explanation is not improbable: 
pleiotropic effects may result from a translation termi-
nation disruption in the sup35 and sup45 mutants. Thus, 
the story of sup35 and sup45 mutations is not finished.
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